跳至主要内容
临床试验/NCT04981821
NCT04981821招募中不适用

A Pilot Randomized Trial of a Mobile Health Exercise Intervention for Older Patients With Myeloid Neoplasms

University of Rochester1 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2022年1月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
170
试验地点
1
主要终点
Difference between experimental and active comparator arms- Physical Function

研究概览

简要总结

This is a phase 2 randomized controlled trial (RCT) to assess the preliminary efficacy of the a mobile health exercise intervention (GO-EXCAP) versus a chemotherapy education control in 100 older patients with MN receiving outpatient chemotherapy on physical function and patient-reported outcomes (fatigue, mood, and quality of life). We will also explore the effect of the intervention on TNFα and related cytokine gene promoter methylation and their gene and protein expression.

详细描述

Up to 98% of older patients with myeloid neoplasms experience physical function decline, fatigue, and mood disturbances. Mobile health exercise interventions are promising strategy to prevent physical function decline and improve fatigue and mood disturbances, but older patients with myeloid neoplasms receiving outpatient chemotherapy are understudied. The proposed study will investigate whether a novel mobile health exercise intervention that is adapted to this population can prevent physical function decline, improve fatigue and mood disturbances, and prevent worsening quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥60 years (conventional definition of older age in clinical trials of MN)
  • Have a diagnosis of MN
  • Planned for or receiving outpatient cancer-directed treatments (participants receiving consolidative or maintenance outpatient therapies after induction chemotherapy are allowed to enroll)
  • English speaking
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-3
  • No medical contraindications for exercise per oncologist
  • Able to walk 4 meters as part of Short Physical Performance Battery measured walk (with or without assistive device)
  • Able to provide informed consent

排除标准

  • Physical, psychological, or social impairments that would interfere with subject's ability to participate in the study or participate in the intervention, as determined by the PI or the treating team

研究组 & 干预措施

GO-EXCAP

Experimental

GO-EXCAP Mobile App involves the use of a mobile app delivery platform to deliver an exercise program [Exercise for Cancer Patients (EXCAP©®)]. EXCAP©®) is a progressive walking and resistance exercise program

干预措施: GO-EXCAP Mobile App (Behavioral)

Behavioral Placebo Control

Active Comparator

Participants will meet with an oncology nurse (for approximately 60 min) to review the NCI booklet Chemotherapy and You: Support for People With Cancer, which includes facts about chemotherapy and its side effects. They will be provided with NCI online resources to review at home.

干预措施: Behavioral Placebo Control (Behavioral)

结局指标

主要结局

Difference between experimental and active comparator arms- Physical Function

时间窗: 12 Weeks

Changes in physical function measured using the Short Physical Performance Battery (SPPB) which an objective physical assessment evaluating lower extremity physical function (score ranges from 0-12; higher score indicates better physical function). It is comprised of 3 components: a four-meter walk, repeated chair stands and a balance test (the score for each component ranges from 0-4).

次要结局

  • Difference between experimental and active comparator arms -Depression(12 Weeks)
  • Difference between experimental and active comparator arms -Quality of Life(12 Weeks)
  • Difference between experimental and active comparator arms -Fatigue(12 Weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kah Poh Loh

Assistant Professor - Department of Medicine , Hematology/Oncology (SMD)

University of Rochester

研究点 (1)

Loading locations...

相似试验

A Randomized Trial of a Mobile Health Exercise... | 临床试验